Rethinking Clinical Trials Reform During the COVID-19 Pandemic
Authors:
Open Access
- 1 September 2020
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA Oncology
- Vol. 6 (9) , 1327-1329
Abstract
This Viewpoint examines how the coronavirus disease 2019 (COVID-19) pandemic is changing the way patients receive access to health care and how these changes caKeywords
This publication has 5 references indexed in Scilit:
- Telehealth transformation: COVID-19 and the rise of virtual careJournal of the American Medical Informatics Association, 2020
- COVID-19 vaccines: breaking record times to first-in-human trialsnpj Vaccines, 2020
- Cancer statistics, 2020CA: A Cancer Journal for Clinicians, 2020
- Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial ParticipationJNCI: Journal of the National Cancer Institute, 2019
- Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer TreatmentJAMA, 2017